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We very much appreciated the interest that Ma et al. [1] have
shown in our work.
As repeatedly pointed out in our article, the data presented
are derived from a literature review, thereby determining the
risk of bias. It must be underlined that the period we are
considering (1936–2013) is signiﬁcantly wider than that
reported by other literature revisions. This fact, along with
an increasing number of cases not described in detail (i.e. the
broad and vague deﬁnition of ‘surgery’, which goes from
drainage to stabilization), makes any ‘surgical intervention’ not
signiﬁcantly associated with a better prognosis in our analysis.
If this conclusion seems to contradict the ones recently
reported by Gamaletsou et al., and by Koehler et al., it must be
considered that in the ﬁrst article the authors found that
antifungal plus surgery was signiﬁcantly associated with fewer
relapses (and not with death, and worsening and chronicity of
infection, as we considered the deﬁnition for negative
outcome) while in the latter paper the combination of
antifungal and surgery was associated with a trend towards a
better survival (78% vs. 60%, not statistically evaluated) as in
our report, although we found the difference less dramatically
evident (62% vs. 58%).
The reason why in our analysis surgical intervention (here
considered to be from drainage of infected tissues to
stabilization) did not inﬂuence the outcome is difﬁcult to
explain. As reported, one can speculate that the patients
treated with the combination of drugs and surgery were those
who were most clinically compromised, and that even such
aggressive therapy could not yield a positive outcome.
Additionally, one important point that needs to be stressed
is that the infections considered in our review ranged from
post-traumatic bone involvement in immunocompetent hosts
to complicated spondylodiscitis in patients with severe under-
lying diseases. The effect of ‘surgical intervention’ was analyzed
in the overall population, and a sub-analysis speciﬁcally
conducted in patients with spondylodiscitis, which might
demonstrate beneﬁcial effects of surgery, was not done in
our study. Unfortunately, not all information was always
available.
We strongly believe that, wherever it is possible, the
combination of antifungal drugs and surgery is the reference
standard in these infections, although here, surgery did not
inﬂuence the outcome of aspergillosis osteomyielitis.
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